Cargando…

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

The human papillomavirus test (HPV) test could improve the (cost−) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a st...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Akker-van Marie, M E, van Ballegooijen, M, Rozendaal, L, Meijer, C J L M, Habbema, J D F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394464/ https://www.ncbi.nlm.nih.gov/pubmed/14612887 http://dx.doi.org/10.1038/sj.bjc.6601355

Ejemplares similares

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.
por: van Ballegooijen, M., et al.
Publicado: (1997)

Low risk of cervical cancer during a long period after negative screening in the Netherlands
por: van den Akker-van Marle, M E, et al.
Publicado: (2003)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
por: Bulk, S, et al.
Publicado: (2007)

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
por: Cuzick, J, et al.
Publicado: (2000)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Non-progression of cervical intraepithelial neoplasia estimated from population-screening data.
por: Bos, A. B., et al.
Publicado: (1997)

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
por: Nobbenhuis, M A E, et al.
Publicado: (2001)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Cervical cancer screening.
por: van Oortmarrsen, G. J., et al.
Publicado: (1990)

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
por: Gök, Murat, et al.
Publicado: (2010)

Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
por: Rebolj, Matejka, et al.
Publicado: (2012)

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
por: Zielinski, G D, et al.
Publicado: (2001)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)

Population Screening for Colorectal Cancer: Faeces, Endoscopes or X-Rays?
por: Ramsoekh, D., et al.
Publicado: (2007)

Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study
por: Jansen, EEL, et al.
Publicado: (2020)

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
por: Bulk, S, et al.
Publicado: (2006)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Public awareness that HPV is a risk factor for cervical cancer
por: Marlow, L A V, et al.
Publicado: (2007)

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
por: Gök, M, et al.
Publicado: (2011)

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
por: Rebolj, Matejka, et al.
Publicado: (2009)

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
por: de Vos van Steenwijk, Peggy J., et al.
Publicado: (2012)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
por: Cuschieri, K, et al.
Publicado: (2010)

HPV infection in women with and without cervical cancer in Conakry, Guinea
por: Keita, N, et al.
Publicado: (2009)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
por: Petry, K-U, et al.
Publicado: (2003)

Preventive Pap-smears: balancing costs, risks and benefits.
por: van Ballegooijen, M., et al.
Publicado: (1992)

Supravaginal hysterectomy in Curaçao prevalence and impact on screening for cervical cancer
por: Hooi, Desiree J., et al.
Publicado: (2017)

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
por: de Kok, I M C M, et al.
Publicado: (2009)

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)

Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area
por: Bulk, S, et al.
Publicado: (2003)

High risk HPV testing for cervical cancer screening in a Puerto Rican population
por: Gustafson, Erik A., et al.
Publicado: (2023)

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
por: Cromme, F. V., et al.
Publicado: (1993)

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer.
por: van Oortmarssen, G. J., et al.
Publicado: (1991)

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis
por: Henken, F E, et al.
Publicado: (2007)

Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women
por: Rocha-Brischiliari, Sheila C, et al.
Publicado: (2014)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test
por: Rijkaart, D C, et al.
Publicado: (2010)

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
por: Chua, Brandon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0jr3cdmrqh7rniu5rc0jhqn11r